A full-service contract research organization, with clinical operations on three continents, has signed an agreement to use TrialMaster EDC from OmniComm Systems, Inc. Under the terms of the agreement, the CRO will use OmniComm’s TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the United Kingdom. The CRO chose TrialMaster to complement an existing in-house EDC system and to provide additional support tools for more complex study designs. The CRO selected OmniComm because of TrialMaster’s built-in patient questionnaire capability, site experience for data collection and easy-to-use study build tools. OmniComm will provide the CRO with technology, training, study development, quality assurance and project management support.